We support research across the
entire spectrum of medical sciences,in
universities and hospitals, in our own
units, centres and institutes in the UK,
and in our units in Africa.

Skip to content


Latest Biomedical Catalyst investments will transform patient outcomes

22 March 2019

Cutting edge projects have received £23 million of government funding under the Biomedical Catalyst, it was announced today. The MRC invested nearly £13.5 million in a number of innovative projects.

MRC scientists discover unique tau filament structures in head-injury associated dementia

20 March 2019

MRC Laboratory of Molecular Biology researchers reveal atomic structures of the abnormal tau filaments associated with chronic traumatic encephalopathy, a head injury-associated neurodegenerative disease, differ in structure from those seen in Alzheimer’s disease.

Nine-month treatment regimen for multi-drug resistant tuberculosis is as effective as 20-months

13 March 2019

A nine to 11-month treatment regimen is as effective in treating multi-drug resistant tuberculosis (MDR-TB) as the 20 to 24-month regimen recommended in 2011 WHO guidelines, according to new research conducted by a team of researchers, including MRC scientists.

FUNDING: Science areas

Researchers can apply for MRC grant funding at any time.


Sign up

email iconKeep up to date with our latest news

Follow MRC on Twitter

MRC Insight: blog